Homograft replacement of mitral valve in children
| Autor: | Jitendra J. Shah, Stephen E Bash, Douglas J. Schneider, Linda M. Bond, Mark D. Plunkett, Dale M. Geiss |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Heart disease Adolescent medicine.medical_treatment Valve replacement Internal medicine Mitral valve medicine Humans Transplantation Homologous cardiovascular diseases Child Mitral regurgitation business.industry Mitral valve replacement Mitral Valve Insufficiency medicine.disease Thrombosis Surgery body regions Transplantation Stenosis surgical procedures operative medicine.anatomical_structure Treatment Outcome Child Preschool cardiovascular system Cardiology Mitral Valve Female Cardiology and Cardiovascular Medicine business |
| Zdroj: | The Annals of thoracic surgery. 66(3) |
| ISSN: | 0003-4975 |
| Popis: | Background. Recent reports have demonstrated successful early outcomes using mitral valve homografts in adults. We report our early results after homograft mitral valve replacement in 4 children with previous atrioventricular septal defects, previous placement of a prosthetic valve, and rheumatic valvular disease. Methods. Between May 1996 and June 1997, 4 children (ages 5, 11, 13, and 15 years) underwent mitral valve replacement with cryopreserved mitral valve homografts at our institution. Preoperative echocardiography confirmed moderately severe to severe mitral regurgitation, stenosis, or both in all 4 patients. Results. Successful homograft valve replacement was achieved in all 4 patients. Based on symptoms, physical examinations, and echocardiographic follow-up, all four homograft mitral valves are functioning well with normal hemodynamics. None of these patients are receiving warfarin. Follow-up has been limited to 10 months. Conclusions. In children requiring mitral valve replacement, the use of mitral valve homografts offers advantages over prosthetic valves, such as the avoidance of complications associated with thrombosis and anticoagulation. Homograft mitral valve replacement is technically feasible in children with congenital and rheumatic heart disease and previous prosthetic valves. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|